Literature DB >> 26042510

Association between Opioid Receptor mu 1 (OPRM1) Gene Polymorphisms and Tobacco and Alcohol Consumption in a Spanish Population.

Francesc Francès1, Olga Portolés, Ana Castelló, Jose Antonio Costa, Fernando Verdú.   

Abstract

Evidence gained from animals and humans suggests that the encephalic opioid system might be involved in the development of drug addiction through its role in reward. Our aim is to assess the influence of genetic variations in the opioid receptor mu 1 on alcohol and tobacco consumption in a Spanish population. 763 unrelated individuals (465 women, 298 men) aged 18-85 years were recruited between October 2011 and April 2012. Participants were requested to answer a 35-item questionnaire on tobacco and alcohol consumption, as well as to complete the AUDIT and Fagerström tests. Individuals were genotyped for three polymorphisms in the opioid receptor mu 1 (OPRM1) gene, using a TaqMan protocol. In males, the rs10485057 polymorphism was associated with total pure ethanol intake and with the risk of being an alcohol consumer. Also, this polymorphism was significantly associated with higher Fagerström scores. Rs1799971 had a different influence on adaptive and maladaptive patterns of alcohol use. Despite the limited sample size, our study might enrich current knowledge on patterns of alcohol use, because it encompasses both extreme and adaptive phenotypes, providing thus a wider perspective on this subject.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26042510      PMCID: PMC4469933          DOI: 10.17305/bjbms.2015.243

Source DB:  PubMed          Journal:  Bosn J Basic Med Sci        ISSN: 1512-8601            Impact factor:   3.363


  33 in total

1.  The functional mu opioid receptor (OPRM1) Asn40Asp variant predicts short-term response to nicotine replacement therapy in a clinical trial.

Authors:  C Lerman; E P Wileyto; F Patterson; M Rukstalis; J Audrain-McGovern; S Restine; P G Shields; V Kaufmann; D Redden; N Benowitz; W H Berrettini
Journal:  Pharmacogenomics J       Date:  2004       Impact factor: 3.550

Review 2.  Ethnic-specific meta-analyses of association between the OPRM1 A118G polymorphism and alcohol dependence among Asians and Caucasians.

Authors:  Dingyan Chen; Li Liu; Yang Xiao; Yuehua Peng; Chengwu Yang; Zengzhen Wang
Journal:  Drug Alcohol Depend       Date:  2011-11-08       Impact factor: 4.492

Review 3.  Association of µ-opioid receptor (OPRM1) gene polymorphism with response to naltrexone in alcohol dependence: a systematic review and meta-analysis.

Authors:  Antonio-Javier Chamorro; Miguel Marcos; José-Antonio Mirón-Canelo; Isabel Pastor; Rogelio González-Sarmiento; Francisco-Javier Laso
Journal:  Addict Biol       Date:  2012-05       Impact factor: 4.280

4.  Influence of OPRM1 Asn40Asp variant (A118G) on [11C]carfentanil binding potential: preliminary findings in human subjects.

Authors:  Elise M Weerts; Mary E McCaul; Hiroto Kuwabara; Xiaoju Yang; Xiaoqiang Xu; Robert F Dannals; J James Frost; Dean F Wong; Gary S Wand
Journal:  Int J Neuropsychopharmacol       Date:  2012-03-08       Impact factor: 5.176

5.  Possible association between OPRM1 genetic variance at the 118 locus and alcohol dependence in a large treatment sample: relationship to alcohol dependence symptoms.

Authors:  Gabriele Koller; Peter Zill; Dan Rujescu; Monika Ridinger; Oliver Pogarell; Christoph Fehr; Norbert Wodarz; Brigitta Bondy; Michael Soyka; Ulrich W Preuss
Journal:  Alcohol Clin Exp Res       Date:  2012-02-06       Impact factor: 3.455

6.  Association of TaqIB polymorphism in the cholesteryl ester transfer protein gene with plasma lipid levels in a healthy Spanish population.

Authors:  D Corella; C Sáiz; M Guillén; O Portolés; F Mulet; J I González; J M Ordovás
Journal:  Atherosclerosis       Date:  2000-10       Impact factor: 5.162

7.  Lack of association of OPRM1 genotype and smoking cessation.

Authors:  Marcus R Munafò; Elaine C Johnstone; Paul Aveyard; Theresa Marteau
Journal:  Nicotine Tob Res       Date:  2012-09-18       Impact factor: 4.244

8.  Effect of the A118G polymorphism on binding affinity, potency and agonist-mediated endocytosis, desensitization, and resensitization of the human mu-opioid receptor.

Authors:  Andrea Beyer; Thomas Koch; Helmut Schröder; Stefan Schulz; Volker Höllt
Journal:  J Neurochem       Date:  2004-05       Impact factor: 5.372

9.  Endogenous opioid receptor genes and alcohol dependence among Taiwanese Han.

Authors:  El Wui Loh; Cathy S J Fann; Yuh Terng Chang; Ching Jui Chang; Andrew T A Cheng
Journal:  Alcohol Clin Exp Res       Date:  2004-01       Impact factor: 3.455

10.  Preliminary evidence for a gene-environment interaction in predicting alcohol use disorders in adolescents.

Authors:  Robert Miranda; Elizabeth Reynolds; Lara Ray; Alicia Justus; Valerie S Knopik; John McGeary; Lori A Meyerson
Journal:  Alcohol Clin Exp Res       Date:  2012-11-08       Impact factor: 3.455

View more
  3 in total

1.  The frequency of DRD2 rs1076560 and OPRM1 rs1799971 in substance use disorder patients from the United Arab Emirates.

Authors:  Hiba Alblooshi; Gary Hulse; Wael Osman; Ahmed El Kashef; Mansour Shawky; Hamad Al Ghaferi; Habiba Al Safar; Guan K Tay
Journal:  Ann Gen Psychiatry       Date:  2018-06-01       Impact factor: 3.455

Review 2.  Lack of associations of the opioid receptor mu 1 (OPRM1) A118G polymorphism (rs1799971) with alcohol dependence: review and meta-analysis of retrospective controlled studies.

Authors:  Xiangyi Kong; Hao Deng; Shun Gong; Theodore Alston; Yanguo Kong; Jingping Wang
Journal:  BMC Med Genet       Date:  2017-10-26       Impact factor: 2.103

3.  Association of opioid receptor mu 1 (OPRM1) A118G polymorphism (rs1799971) with nicotine dependence.

Authors:  Xiangyi Kong; Hao Deng; Theodore Alston; Yanguo Kong; Jingping Wang
Journal:  Oncotarget       Date:  2017-09-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.